<code id='9CD96A81EB'></code><style id='9CD96A81EB'></style>
    • <acronym id='9CD96A81EB'></acronym>
      <center id='9CD96A81EB'><center id='9CD96A81EB'><tfoot id='9CD96A81EB'></tfoot></center><abbr id='9CD96A81EB'><dir id='9CD96A81EB'><tfoot id='9CD96A81EB'></tfoot><noframes id='9CD96A81EB'>

    • <optgroup id='9CD96A81EB'><strike id='9CD96A81EB'><sup id='9CD96A81EB'></sup></strike><code id='9CD96A81EB'></code></optgroup>
        1. <b id='9CD96A81EB'><label id='9CD96A81EB'><select id='9CD96A81EB'><dt id='9CD96A81EB'><span id='9CD96A81EB'></span></dt></select></label></b><u id='9CD96A81EB'></u>
          <i id='9CD96A81EB'><strike id='9CD96A81EB'><tt id='9CD96A81EB'><pre id='9CD96A81EB'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:11151
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Readout Newsletter: Medeor's stem cell study, Moderna's stock dip
          Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

          RogelioV.Solis/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          GSK Flovent asthma inhalers replaced by authorized generics

          AdobeAsofJan.1,thousandsofasthmapatientsintheU.S.willnolongerbeabletogetrefillsforFlovent—oneofthemo